Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.

导出 LinkOut

翻译打印收藏纠错

作者： Eleonora,Vecchio ^[1] ; Rossana,Marino ^[2] ; Selena,Mimmi ^[1] ; Camilla,Canale ^[2] ; Carmen,Caiazza ^[2] ; Alessandro,Arcucci ^[3] ; Maria Rosaria,Ruocco ^[2] ; Marco,Schiavone ^[4] ; Gianluca,Santamaria ^[1] ; Camillo,Palmieri ^[1] ; Enrico,Iaccino ^[1] ; Massimo,Mallardo ^[2] ; Ileana,Quinto ^[1] ; Giuseppe,Fiume ^[1]

作者单位： Department of Experimental and Clinical Medicine, University Magna Græcia of Catanzaro, Catanzaro, Italy. ^[1] Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", Naples, Italy. ^[2] Department of Public Health, University of Naples "Federico II", Naples, Italy. ^[3] Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. ^[4]

关键词 IBTK MYC apoptosis non-Hodgkin’s lymphoma rituximab

DOI 10.3389/fonc.2024.1339584

PMID 38371626

发布时间 2024-02-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2024年14卷

1339584页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除